LILAC INVESTMENTS LIMITED
Institution · data to Jun 2026
Disclosed value
₹2,380 Cr
Jun 2026 closes
At current prices
…
Current holdings
2
Tracked since
Sep 2024
Portfolio value over time
Sum of disclosed holdings across all combined entities, valued at each quarter's closing price.
Current holdings (Jun 2026)
| Company | Holding | QoQ | Value |
|---|---|---|---|
| ERIS Lifesciences Ltd | 8.63% | 0.01 | ₹1,712 Cr |
| Krishna Institute of Medical Sciences Ltd | 1.87% | 0.09 | ₹668 Cr |
Portfolio Summary
Jun 2026As of Jun 2026, LILAC INVESTMENTS LIMITED — an institution tracked through public shareholding filings — disclosed 2 holdings in Indian listed companies worth ₹2,380 crore. The same holdings-at-filing-value basis put it at ₹2,086 crore in Mar 2026 (+14.1%). Solomo carries these filings back to Sep 2024.
Largest disclosed positions in Jun 2026: ERIS Lifesciences Ltd (ERIS — 8.63% of the company, ₹1,712 crore); Krishna Institute of Medical Sciences Ltd (KIMS — 1.87% of the company, ₹668 crore).
Changes in the Jun 2026 filings: Stake reduced in Krishna Institute of Medical Sciences Ltd (−0.09 pp), ERIS Lifesciences Ltd (−0.01 pp).
| Quarter | Disclosed value | Change |
|---|---|---|
| Jun 2026 | ₹2,380 Cr | +14.1% |
| Mar 2026 | ₹2,086 Cr | −10.5% |
| Dec 2025 | ₹2,331 Cr | −4.8% |
| Sep 2025 | ₹2,448 Cr | −5.1% |
| Jun 2025 | ₹2,581 Cr | +26.1% |
| Mar 2025 | ₹2,047 Cr | +0.1% |
| Dec 2024 | ₹2,045 Cr | +15.7% |
| Sep 2024 | ₹1,767 Cr | - |